Pure Global AI
Authorised representative profile

Coopervision Hong Kong Limited

酷柏光学(香港)有限公司
Hong Kong MDACS66 represented devices12 applicantsNov 20, 2014 – Oct 15, 2024
VerifiedMDD (Medical Device Division) · MDACS registry
66
Total devices
12
Applicants
2014
First representation
2024
Most recent
AR overview
Authorised representative (EN)
Coopervision Hong Kong Limited
Authorised representative (ZH)
酷柏光学(香港)有限公司
Phone
37180688
Timeline
First representation
Nov 20, 2014
Most recent
Oct 15, 2024
Regulatory footprint
Search Coopervision Hong Kong Limited across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk class distribution
II58
III8
Applicant partnerships
Top manufacturers represented by this AR
CooperVision Inc
15 devices
CooperVision, Inc.
10 devices
CooperVision Inc.
9 devices
Sauflon Pharmaceuticals Ltd.
8 devices
Coopervision, Inc.
4 devices
CooperVision, Inc
4 devices
Coopervision Inc
4 devices
Coopervision Inc.
4 devices
COOPERVISION, INC.
3 devices
SAUFLON PHARMACEUTICALS LIMITED
3 devices
Recent registrations
Latest 15 MDACS listings represented by Coopervision Hong Kong Limited
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Oct 15, 2024
Risk class
II
Applicant
CooperVision Inc.CooperVision Inc.
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Sep 20, 2024
Risk class
II
Applicant
CooperVision, Inc.CooperVision, Inc.
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Sep 02, 2024
Risk class
II
Applicant
CooperVision, Inc.CooperVision, Inc.
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Sep 02, 2024
Risk class
II
Applicant
CooperVision, Inc.CooperVision, Inc.
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Jul 08, 2024
Risk class
II
Applicant
CooperVision IncCooperVision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Jul 08, 2024
Risk class
II
Applicant
CooperVision IncCooperVision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Jul 08, 2024
Risk class
II
Applicant
CooperVision IncCooperVision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Jun 24, 2024
Risk class
II
Applicant
CooperVision IncCooperVision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
May 22, 2024
Risk class
II
Applicant
Coopervision IncCoopervision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Feb 19, 2024
Risk class
II
Applicant
CooperVision, IncCooperVision, Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Jan 31, 2024
Risk class
II
Applicant
CooperVision, Inc.CooperVision, Inc.
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Dec 22, 2023
Risk class
II
Applicant
Coopervision IncCoopervision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Sep 22, 2023
Risk class
II
Applicant
Coopervision IncCoopervision Inc
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Jul 26, 2023
Risk class
II
Applicant
CooperVision Inc.CooperVision Inc.
Contact Lenses, Vision Corrective
隐形眼镜,视力矫正
Apr 04, 2023
Risk class
II
Applicant
CooperVision, IncCooperVision, Inc
View all 66 devices →
About this profile

Coopervision Hong Kong Limited serves as the authorised representative for 66 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.